Skip to content
Riskpilot
← Back to search
Sign in
Sign in
Get full access
JoY Pharma AB
AB
Active
Org 5592065402
Skällnoravägen 6, 168 39
Bromma
Research and experimental development on natural sciences and engineering
·
NACE 7210
Est. 2019 · 7 years old
1 employees
Monitor
Share
Sweden
/
Companies
/
Research and experimental development on natural sciences and engineering
/
JoY Pharma AB
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
SEK millions
2M
2M
1M
1M
0M
2021: 2M
2M
2021
2022: 2M (0% vs 2021)
2M
0%
2022
2023: 2M (0% vs 2022)
2M
0%
2023
2024: 1M (-50% vs 2023)
1M
-50%
2024
2025: 0M (-100% vs 2024)
0M
-100%
2025
EBITDA
SEK millions
1M
1M
1M
0M
0M
2021: 1M
1M
2021
2022: 1M (0% vs 2021)
1M
0%
2022
2023: 1M (0% vs 2022)
1M
0%
2023
2024: 0M (-100% vs 2023)
0M
-100%
2024
2025: 0M
0M
2025
Income statement
SEK thousands
Item
2025
2024
2023
2022
2021
Revenue
482
1 343
2 094
1 972
1 919
Staff expenses
−310
−840
−835
−800
—
EBITDA
96
425
1 198
1 103
1 083
Depreciation & amort.
—
—
—
—
−0
EBIT
96
425
1 198
1 103
1 083
Net financials
929
8
3
−0
—
Profit before tax
1 100
323
901
1 103
813
Tax
−42
−72
−188
−228
−168
Net profit
1 057
251
712
875
645
Balance sheet
SEK thousands
Item
2025
2024
2023
2022
2021
Total assets
4 497
3 820
3 837
3 155
2 592
Equity
3 329
2 571
2 621
2 208
1 634
Long-term debt
—
—
—
—
0
Short-term debt
93
98
176
206
218
Total debt
93
98
176
206
218
Financial ratios
5-year trend
EBITDA margin
20,0 %
This company
15,8 %
Market median
This company
Market median
27% above market
2021
2025
Equity ratio
74,0 %
This company
38,2 %
Market median
This company
Market median
94% above market
2021
2025
Return on equity
31,8 %
This company
18,4 %
Market median
This company
Market median
73% above market
2021
2025
Net profit margin
219,4 %
This company
8,1 %
Market median
This company
Market median
>999% above market
2021
2025
Asset turnover
0,11×
This company
1,12×
Market median
This company
Market median
90% below market
2021
2025
Debt / equity
0,35×
This company
0,62×
Market median
This company
Market median
44% below market
2021
2025
Annual reports & filings
Annual report 2025
Filed via Bolagsverket / SCB · Period 2025-01-01 – 2025-12-31
View
PDF
Annual report 2024
Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
View
PDF
More on JoY Pharma AB
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
